06:00 PM EDT, 10/04/2024 (MT Newswires) -- Timothy A Springer, 10% Owner, Director, on October 02, 2024, executed a purchase for 205,721 shares in Cartesian Therapeutics ( RNAC ) for $4,293,545. Following the Form 4 filing with the SEC, Springer has control over a total of 8,023,766 shares of the company, with 8,023,766 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1453687/000145368724000115/xslF345X05/wk-form4_1728079086.xml

Price: 25.22, Change: +0.70, Percent Change: +2.85